ArticleSubstance use & misuse2025
Predictors of Awareness of Fentanyl Test Strips Among People Who Inject Drugs in Northeast Georgia.
Article in Substance use & misuse, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundFentanyl test strips may help People who inject drugs in detecting fentanyl in street drugs and thereby reduce the risk of overdose deaths. This study aims to determine the predictors of FTS awareness among PWID living in Northeast Georgia.
methodsAdults (≥18 years) with a recent history of injection drug use (IDU) were surveyed between February and December 2023 (
resultsLess than half (45.3%) of the PWID were aware of FTS. In the multivariable model, the odds of FTS awareness were higher among PWID who attended SSP (adjusted Odds Ratio [aOR]: 2.30, 95% Confidence Interval [95%CI]: 1.10, 4.79) than those who did not. Awareness of FTS was also higher among individuals with high IDU-related stigma (aOR: 2.74, 95%CI: 1.34, 5.60) than those who had low stigma. African American PWID were less likely to be aware of FTS (aOR: 0.26, 95%CI: 0.11, 0.61) than White PWID.
conclusionsFTS awareness is a critical first step for PWID to engage in harm reduction strategies for fentanyl overdose prevention. Findings highlight the need for innovative approaches to educate PWID who are not engaged in SSP services about the benefits of FTS. Tailored approaches for certain communities of people who use drugs are also urgently needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.